SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-15-004430
Filing Date
2015-09-29
Accepted
2015-09-29 09:55:50
Documents
29
Period of Report
2015-09-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ptx_8k.htm 8-K 30910
2 PRESENTATION OF THE COMPANY DATED SEPTEMBER 2015 ptx_ex91.htm EX-99.1 26142
3 slide1.jpg GRAPHIC 46740
4 slide2.jpg GRAPHIC 60575
5 slide3.jpg GRAPHIC 44780
6 slide4.jpg GRAPHIC 41052
7 slide5.jpg GRAPHIC 42580
8 slide6.jpg GRAPHIC 56975
9 slide7.jpg GRAPHIC 55174
10 slide8.jpg GRAPHIC 38285
11 slide9.jpg GRAPHIC 44814
12 slide10.jpg GRAPHIC 45141
13 slide11.jpg GRAPHIC 36672
14 slide12.jpg GRAPHIC 37836
15 slide13.jpg GRAPHIC 62519
16 slide14.jpg GRAPHIC 50161
17 slide15.jpg GRAPHIC 39928
18 slide16.jpg GRAPHIC 48079
19 slide17.jpg GRAPHIC 47545
20 slide18.jpg GRAPHIC 58418
21 slide19.jpg GRAPHIC 36627
22 slide20.jpg GRAPHIC 41264
23 slide21.jpg GRAPHIC 47939
24 slide22.jpg GRAPHIC 32765
25 slide23.jpg GRAPHIC 39105
26 slide24.jpg GRAPHIC 36111
27 slide25.jpg GRAPHIC 34403
28 slide26.jpg GRAPHIC 53235
29 slide27.jpg GRAPHIC 30727
  Complete submission text file 0001354488-15-004430.txt   1727100
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14494 | Film No.: 151129039
SIC: 2834 Pharmaceutical Preparations